PepGen Inc. (PEPG)
2.52
-0.18
(-6.67%)
USD |
NASDAQ |
Oct 23, 16:00
2.53
+0.01
(+0.40%)
After-Hours: 20:00
PepGen Shareholders Equity (Quarterly) : 119.53M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 119.53M |
| March 31, 2026 | 133.98M |
| December 31, 2025 | 147.44M |
| September 30, 2025 | 163.14M |
| June 30, 2025 | 71.16M |
| March 31, 2025 | 91.80M |
| December 31, 2024 | 118.62M |
| September 30, 2024 | 137.46M |
| June 30, 2024 | 155.04M |
| March 31, 2024 | 179.00M |
| December 31, 2023 | 108.42M |
| September 30, 2023 | 125.86M |
| Date | Value |
|---|---|
| June 30, 2023 | 147.28M |
| March 31, 2023 | 164.84M |
| December 31, 2022 | 179.63M |
| September 30, 2022 | 192.94M |
| June 30, 2022 | 210.22M |
| March 31, 2022 | 115.59M |
| December 31, 2021 | 133.09M |
| September 30, 2021 | 139.57M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 9.774M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.40M |
| Total Liabilities (Quarterly) | 21.86M |
| Debt to Equity Ratio | 0.1346 |
| Current Ratio | 13.36 |
| Net Debt Paydown Yield | 0.35% |